Penetration of VP-16 (etoposide) into human intracerebral and extracerebral tumors (original) (raw)
References
Issell BF, Crooke AF: Etoposide (VP-16–213). Cancer Treat Rep 6:107–124, 1979. Google Scholar
Dorr RT, Fritz WL: Cancer chemotherapy handbook. Elsevier North Holland Inc, New York, 1980. Google Scholar
Arnold AM: Podophyllotoxin derivative VP-16–213. Cancer Chemother Pharmacol 3:71–80, 1979. Google Scholar
Schmoll H: Review of etoposide single-agent activity. Cancer Treat Reviews 9 (Suppl A):21–30, 1982. Google Scholar
Sklansky BD, Mann-Kaplan RS, Reynolds AF, Rosenblum ML, Walker MD: 4′-demethyl-epipodophyllotoxin-B-D-thenylidene-glucoside (PTG) in the treatment of malignant intracranial neoplasms. Cancer 33:460–467, 1974. Google Scholar
Creaven PJ: The clinical pharmacology of VM-26 and VP-16–213. A brief overview. Cancer Chemother Pharmacol 7:133–140, 1982. Google Scholar
D'Incalci M, Farina P, Sessa C, Mangioni C, Confer V, Masera G, Rocchetti M, Brambilla Pisoni M, Piazza E, Beer M, Cavalli F: Pharmacokinetics of VP-16–213 given by different administration methods. Cancer Chemother Pharmacol 7:141–145, 1982. Google Scholar
Colombo T, Groggini M, Torti L, Erba E, D'Incalci M: Pharmacokinetics of Vp-16–213 in Lewis lung carcinoma-bearing mice. Cancer Chemother Pharmacol 7:127–131, 1982. Google Scholar
Savaraj N, Lu K, Rauston GL, Feun LG, Loo TL: Comparison of CNS penetration, tissue distribution, and pharmacology of 4′-demethyl epipodophyllotoxin 9-(4,5-O-ethylidene-B-D-glucopyranoside). (VP-16, NSC-141540). Intracarotid (IC) vs intravenous (IV) administration in dogs. Prc AACR 23:201, 1982. Google Scholar
Hirano A, Matsui T: Vascular structures in brain tumors. Human Pathol 6:611, 1975. Google Scholar
Groothuis DR, Fischer JM, Vick NA, Bigner DD: Comparative permeability of different glioma models to horseradish peroxidase. Cancer Treat Rep 65 (Suppl 2):13–18, 1981. Google Scholar
Levin VA: A pharmacologic basis for brain tumor chemotherapy. Sem Oncol 2:57, 1975. Google Scholar
Stewart DJ, Leavens M, Maor M, Feun L, Luna M, Bonura J, Caprioli R, Loo, TL, Benjamin RS: Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer is malignant brain tumors. Cancer Research 42:2474–2479, 1982. Google Scholar
Stewart DJ, Leavens M, Friedman J, Benjamin RS, Moore EC, Bodey GP, Valdivieso M, Burgess MA, Wiseman C, Loo TL: Penetration of N-(phosphonacetyl)-L-aspartate into human central nervous system and intracerebral tumor. Cancer Research 40:3163–3166, 1980. Google Scholar
Rosenblum M, Stewart DJ, Yap BS, Leavens M, Benjamin RS, Loo TL: Penetration of methylglyoxal bis (guanylhydrazone) into intracerebral tumors in humans. Cancer Research 41:459–462, 1981. Google Scholar
Stewart DJ, Lu K, Benjamin RS, Leavens M, Luna M, Yap HY, Loo TL: Concentration of vinblastine in human intracerebral tumor and other tissues. J Neuro-Oncol 1:139–144, 1983. Google Scholar
Stewart DJ, Benvenuto JA, Leavens M, Hall SW, Benjamin RS, Plunkett W, McCredie KD, Burgess MA, Loo TL: Penetration of 3-deazauridine into human brain, intracerebral tumor, and cerebrospinal fluid. Cancer Research 39:4119–4122, 1979. Google Scholar
Fong KL, Ho DHW, Yap BS, Stewart DJ, Brown NS, Benjamin RS, Freireich EJ, Bodey GP: Clinical pharmacology of IMPY by radio-immunoassay. Cancer Treatment Rep 64:1253–1260, 1980. Google Scholar
Stewart DJ, Richard M, Hugenholtz H, Dennery J: VP-16 (VP) and VM-26 (VM) penetration into human brain tumors (BT). Proc Am Assoc Cancer Res 1983.
Stewart DJ, Benvenuto J, Leavens M, Smith R, Benjamin RS, Loo TL: Central nervous system clinical pharmacology of pentamethylmelamine. J Neuro-Oncol 1:357–364 1982. Google Scholar
Evans WE, Sinkule JA, Crom WR, Dow L, Look T, Rivera G: Pharmacokinetics of teniposide (VM-26) and etoposide (VP-16–213) in children with cancer. Cancer Chemother Pharmacol 7:147–150, 1982. Google Scholar
Neuwelt EA, Diehl JT, Vu LH, Hill SA, Michael AJ, Frenkel EP: Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood-brain barrier disruption. Ann Intern Med 94:449–454, 1981. Google Scholar
Savaraj N, Lu K, Fenn LG, Leavens ME, Stewart DJ, Burgess MA, Benjamin RS, Loo TL: Intracerebral penetration and tissue distribution of 2,5-diaziridinyl 3,6-bis(carboethoxyamino)1,4-benzoquinone, (AZQ NSC 182986). J Neuro-Oncol 1:15–20, 1983. Google Scholar
Broder LE, Rall DP: Chemotherapy of brain tumors. Prog Exp Tumor Res 17:373–399, 1972. Google Scholar
Stewart DJ, Benjamin RS, Luna M, Seifert WE, Loo TL: Human tissue distribution of platinum after cis-diammine-dichloroplatinum. Cancer Chemother & Pharm 10: 51–54, 1982. Google Scholar
Stewart DJ, Nundy D, Maroun JA, Tetreault L, Prior J: Bioavailability, pharmacokinetics and clinical effects of an oral preparation of etoposide (VP-16 213, NSC 141540). Cancer Treat Report (in press).